The clinical and economic impact of a secondary heart disease prevention clinic jointly implemented by a practice nurse and pharmacist

Pharmacy World and Science

Volumn 25, Issue 6, 2003, Pages 294-298

  Reilly, Val ^b   Cavanagh, Margaret ^a  

^a Burnbank Medical Centre   (United Kingdom)

^b NONE

Author keywords

Cardiovascular heart disease; Pharmacist; Practice nurse; Primary care; Scotland; Secondary heart disease prevention

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR;

ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; COMORBIDITY; COST CONTROL; DIABETES MELLITUS; DRUG COST; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; NURSE; PATIENT COUNSELING; PATIENT SATISFACTION; PHARMACEUTICAL CARE; PHARMACIST; PRIMARY MEDICAL CARE; RISK FACTOR; RISK MANAGEMENT; SECONDARY PREVENTION; UNITED KINGDOM;

ADRENERGIC BETA-ANTAGONISTS; AGED; ASPIRIN; CARDIOVASCULAR DISEASES; CLINICAL PROTOCOLS; DIET; EXERCISE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; NURSES; PHARMACISTS; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; RISK FACTORS; SMOKING;

EID: 0344664408     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:PHAR.0000006526.55922.8d     Document Type: Article

References (20)

1. Scottish Office Department of Health. Health in Scotland 2000. Edinburgh: The Stationery Office, 2000.
2. Scottish Office Department of Health. Scotland's Health: Scottish Health Survey 1998. Edinburgh: The Stationery Office, 2000.
3. Scottish Intercollegiate Guidelines Network (SIGN). Management of Diabetic Cardiovascular Disease. Edinburgh: SIGN, 1997 (SIGN publication no.19).
4. Scottish Intercollegiate Guidelines Network (SIGN). Drug Therapy for Peripheral Vascular Disease. Edinburgh: SIGN, 1998 (SIGN publication no. 27).
5. Scottish Intercollegiate Guidelines Network (SIGN). Antithrombotic Therapy. Edinburgh: SIGN, 1999 (SIGN publication no. 36).
6. Scottish Intercollegiate Guidelines Network (SIGN). Lipids and the Primary Prevention of Coronary Heart Disease. Edinburgh: SIGN, 1999 (SIGN publication no. 40).
7. Scottish Intercollegiate Guidelines Network (SIGN). Management of Stable Angina. Edinburgh: SIGN, 2001 (SIGN publication no. 51).
8. Scottish Intercollegiate Guidelines Network (SIGN). Secondary Prevention of Coronary Heart Disease. Edinburgh: SIGN, 2000. (SIGN publication no. 41).
9. Wood D, Durrington P, Poulter N, McInnes G, Rees A, Wray R on behalf of the British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, and British Diabetic Association. Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart 1999; 80 (Suppl 2) S1-S29.
10. Lanarkshire Prescribing Advisers Guidelines. Lanarkshire Prescribing Advisers. Lanarkshire, UK: Lanarkshire Primary Care Trust, 1999.
11. Greater Glasgow Health Gain Commissioning Team. Greater Glasgow Health Board (GGHB) Guidelines for Cholesterol Management. Glasgow, 1999.
12. World Health Organisation (Europe) and International Diabetes Federation (Europe). Diabetes Care and Research in Europe; the St Vincent Declaration. Diabetes Med 1990; 7: 360-70.
13. Collaborative overview of randomised trials of anti-platelet therapy-I: Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration. BMI 1994; 308:81-106.
14. Eccles M, Freemantle N, Mason J. North of England evidence based Guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care. North of England Aspirin Guideline Development Group. BMJ 1998; 316:1303-9.
15. The Beta Blocker Pooling Project (BBPP): subgroup findings from randomised trials in post infarction patients. The Beta Blocker Pooling Project Research Group. Eur Heart J 1988; 9: 8-16.
16. Ebrahim S, Smith GD. Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease. BMJ 1997; 314 1666-74
17. Wilhelmsson C. Coronary heart disease; epidemiology of smoking and intervention studies of smoking. Am Heart J 1988;115:242-9
18. ASH Scotland/Health Education Board for Scotland. Breaking down the barriers. Women low income and smoking. Final Report. Edinburgh, 1999.
19. Department of Health. Smoking Kills: A White Paper on Tobacco. London: The Stationery Office, 1998.
20. Bradley TJ, Round AP, Ramsden M. The success of an evidence based raional prescribing intervention: A retrospective study. Pharm J 2000; 265 (Jul 1) 25-29.